Skip to main navigation
Skip to search
Skip to main content
Houston Methodist Scholars Home
Home
Experts
Research units
Cores
Projects
Research output
Prizes
Search by expertise, name or affiliation
View Scopus Profile
Qing Yi, MD, PhD
Ralph O’Connor Centennial Chair
,
Dr. Mary and Ron Neal Cancer Center
Professor of Cancer Biology in Medicine
,
Academic Institute
Member, Research Institute
,
Academic Institute
Department of Medicine
Associate Director, Cancer Center Basic Research Programs
,
Dr. Mary and Ron Neal Cancer Center
Houston Methodist
Weill Cornell Medical College
h-index
11197
Citations
59
h-index
Calculated based on number of publications stored in Pure and citations from Scopus
1991 …
2025
Research activity per year
Overview
Fingerprint
Network
Projects
(17)
Research output
(209)
Similar Profiles
(6)
Fingerprint
Dive into the research topics where Qing Yi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Immunology and Microbiology
Multiple Myeloma
100%
T Cell
66%
Myeloma Cell
54%
Immunotherapy
41%
Dendritic Cell
41%
Idiotype
30%
Programmed Cell Death
24%
Cytotoxic T-Cell
23%
B Cell
23%
Myasthenia gravis
19%
Immune Response
17%
Peptides
16%
Monoclonal Antibody
16%
Tumor Cell
15%
Macrophage
14%
Th9 Cell
13%
Lymphoma Cell
13%
Tumor Antigen
12%
Interleukin 6
12%
Cytotoxic T Cell
12%
Osteoclast
10%
Immune System
10%
Monoclonal Immunoglobulinemia
10%
Immunity
10%
Mouse Model
10%
Dectin 1
9%
Interleukin 2
9%
CD8
9%
T-Helper Cell
8%
Cytokine
8%
Mitogen
7%
Cell Differentiation
7%
Antineoplastic Activity
7%
Drug Resistance
7%
Tumor Immunity
7%
Regulatory T Cell
7%
Interferon
7%
CD4
6%
Mantle Cell Lymphoma Cell
6%
Cell Survival
6%
Lenalidomide
6%
Dendritic Cell Vaccine
6%
T Cell Subset
6%
Secretion (Process)
6%
Osteoclastogenesis
6%
Antigen-Presenting Cell
6%
Cytotoxicity
6%
Heat Shock
5%
Myeloma Cell Line
5%
Cancer Cell
5%
Keyphrases
Multiple Myeloma
37%
Myeloma
29%
T Cells
17%
Dendritic Cells
16%
Myeloma Cells
16%
Idiotype
15%
β2-microglobulin (β2-MG)
11%
Myasthenia Gravis
9%
Monoclonal Antibody
8%
Macrophages
8%
Mantle Cell Lymphoma
7%
Tumor Cells
7%
Tumor Antigen
7%
Cell-based
7%
MHC Class II
7%
Antigen-presenting Cells
6%
Bortezomib
6%
Th9 Cells
5%
Immune System
5%
CD8+ T Cells
5%
Induced Apoptosis
5%
Osteoclast
5%
Cancer Immunotherapy
5%
Medicine and Dentistry
Multiple Myeloma
35%
T Cell
23%
Myeloma
22%
Neoplasm
19%
Dendritic Cell
16%
Myeloma Cell
15%
Immunoglobulin Idiotype
13%
Immunotherapy
12%
Cytotoxic T-Cell
8%
Mantle Cell Lymphoma
7%
Tumor Cell
7%
B Cell
7%
In Vitro
7%
Monoclonal Gammopathy of Undetermined Significance
6%
Mitogen Activated Protein Kinase P38
6%
Mantle Cell Lymphoma Cell
6%
Programmed Cell Death
6%
Th9 Cell
5%
Cancer
5%
T-Cell Response
5%
Osteoclast
5%
